Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

International variation in management of screen-detected ductal carcinoma in situ of the breast.

Ponti A, Lynge E, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Mano MP, Kawai M, Scharpantgen A, Fracheboud J, Hofvind S, Vidal C, Ascunce N, Salas D, Bulliard JL, Segnan N, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Oct;50(15):2695-704. doi: 10.1016/j.ejca.2014.07.019. Epub 2014 Aug 19.

2.

Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.

Nicholson S, Hanby A, Clements K, Kearins O, Lawrence G, Dodwell D, Bishop H, Thompson A; Sloane Project Steering Group.

Eur J Surg Oncol. 2015 Jan;41(1):86-93. doi: 10.1016/j.ejso.2014.09.003. Epub 2014 Oct 16.

PMID:
25441934
3.

Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.

van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, van de Poll-Franse LV.

Breast. 2014 Feb;23(1):63-8. doi: 10.1016/j.breast.2013.11.001. Epub 2013 Dec 2.

PMID:
24291376
4.

The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.

Coromilas EJ, Wright JD, Huang Y, Feldman S, Neugut AI, Chen L, Hershman DL.

JAMA Oncol. 2015 Jun;1(3):323-32. doi: 10.1001/jamaoncol.2015.0389.

PMID:
26181180
5.

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

Virnig BA, Tuttle TM, Shamliyan T, Kane RL.

J Natl Cancer Inst. 2010 Feb 3;102(3):170-8. doi: 10.1093/jnci/djp482. Epub 2010 Jan 13. Review.

PMID:
20071685
6.

Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.

Sakorafas GH, Tsiotou AG.

Cancer Treat Rev. 2000 Apr;26(2):103-25. Review.

PMID:
10772968
7.

Trends in the treatment of ductal carcinoma in situ of the breast.

Baxter NN, Virnig BA, Durham SB, Tuttle TM.

J Natl Cancer Inst. 2004 Mar 17;96(6):443-8.

PMID:
15026469
8.

Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Jan;50(1):185-92. doi: 10.1016/j.ejca.2013.08.013. Epub 2013 Sep 13.

9.

Optimal management of ductal carcinoma in situ of the breast.

Sakorafas GH, Farley DR.

Surg Oncol. 2003 Dec;12(4):221-40. Review.

PMID:
14998563
10.

Diagnosis and management of ductal carcinoma in situ (DCIS).

Virnig BA, Shamliyan T, Tuttle TM, Kane RL, Wilt TJ.

Evid Rep Technol Assess (Full Rep). 2009 Sep;(185):1-549. Review.

11.

Management of women with ductal carcinoma in situ of the breast: a population-based study.

Verkooijen HM, Fioretta G, De Wolf C, Vlastos G, Kurtz J, Borisch B, Schäfer P, Spiliopoulos A, Sappino AP, Renella R, Pittet B, Schmid De Gruneck J, Wespi Y, Neyroud-Caspar I, Bouchardy C.

Ann Oncol. 2002 Aug;13(8):1236-45.

PMID:
12181247
12.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
13.

Factors predicting microinvasion in Ductal Carcinoma in situ.

Ozkan-Gurdal S, Cabioglu N, Ozcinar B, Muslumanoglu M, Ozmen V, Kecer M, Yavuz E, Igci A.

Asian Pac J Cancer Prev. 2014;15(1):55-60.

14.

The management of ductal carcinoma in situ of the breast: a screened population-based analysis.

Rakovitch E, Pignol JP, Chartier C, Hanna W, Kahn H, Wong J, Mai V, Paszat L.

Breast Cancer Res Treat. 2007 Mar;101(3):335-47. Epub 2006 Jul 13.

PMID:
16838110
15.

Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.

Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, Bornstein BA, McNeese M, Schultz DJ, Fowble BL, Barrett W, Yeh IT, Kurtz JM, Amalric R, Fourquet A.

Cancer J Sci Am. 1996 May-Jun;2(3):158-65.

PMID:
9166516
16.

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.

Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE.

Breast Cancer Res Treat. 2006 Aug;98(3):311-4. Epub 2006 Mar 22.

PMID:
16552627
17.

National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.

Cuncins-Hearn A, Boult M, Babidge W, Zorbas H, Villanueva E, Evans A, Oliver D, Kollias J, Reeve T, Maddern G.

ANZ J Surg. 2007 Jan-Feb;77(1-2):64-8.

PMID:
17295824
18.

Patient preferences for axillary dissection in the management of early-stage breast cancer.

Galper SR, Lee SJ, Tao ML, Troyan S, Kaelin CM, Harris JR, Weeks JC.

J Natl Cancer Inst. 2000 Oct 18;92(20):1681-7.

PMID:
11036114
19.

Ductal carcinoma in situ with microinvasion.

Adamovich TL, Simmons RM.

Am J Surg. 2003 Aug;186(2):112-6. Review.

PMID:
12885600
20.

Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.

Chin-Lenn L, Mack LA, Temple W, Cherniak W, Quinn RR, Ravani P, Lewin AM, Quan ML.

Ann Surg Oncol. 2014 Jan;21(1):66-73. doi: 10.1245/s10434-013-3239-4. Epub 2013 Sep 18.

PMID:
24046105

Supplemental Content

Support Center